Stock Events

Eterna Therapeutics (ERNA) Q4 2023 Earnings

14MarConfirmed
Nov 22
Q4 2022
Q3 2023
Q4 2023
-2.49
-2
-1.52
-1.03

Details

Expected EPS
N/A
Actual EPS
-1.14
Surprise EPS
-1.14
Surprise Percent
+∞%

Description

Eterna Therapeutics (ERNA) has reported earnings of -1.14 per share for Q4 2023.

0 Comments

Share your thoughts